DTaP Vaccine Offers High Protection for Children
Children receiving three or more doses of the DTaP vaccine show a 96.2% effectiveness rate against pertussis.
Updated on Oct. 16, 2026 in Allergies
Live Poll
Do you believe it is essential for children to complete the full childhood vaccine series?
A 2024 study of a pertussis outbreak in Alaska reveals that children who received three or more DTaP vaccine doses were 96.2% protected against infection. Unvaccinated children faced 26 times the odds of contracting the illness compared to their vaccinated peers.
Why it matters
The findings highlight the critical role of the multi-dose DTaP series in preventing pertussis, which remains a severe health risk after 16 deaths were recorded across the United States in 2025. National vaccination coverage has declined to 92.0% for the 2025-26 school year, down from 95.2% in 2017-18.
This retrospective study analyzed vaccination records of children aged six months to six years during the 2024 Alaska pertussis outbreak, comparing those with varying DTaP coverage against a control group. While demonstrating high protection for multi-dose recipients, the exact duration of this immunity beyond the study window remains under investigation.
The players
VacTrAK
The immunization information system used in Alaska to maintain vaccination records.
Morbidity and Mortality Weekly Report
A publication from the CDC that provides essential data and reports on public health topics.
The details
The DTaP vaccine is a five-dose series given from two months to six years of age to build immunity against diphtheria, tetanus, and pertussis. By comparing children diagnosed with pertussis against a control group treated for acute coughs, researchers assessed how varied dose counts influence infection risk. The data indicates that completing the initial stages of the series provides significantly higher protection than being undervaccinated or having no doses at all.
Timeline
2017-18: The US kindergartner DTaP vaccination rate was 95.2%.
2024: Alaska experienced its highest pertussis case rate on record.
2025: 16 people died from pertussis in the United States.
2025-26: The US kindergartner DTaP vaccination rate fell to 92.0%.
- 2026-10-15
The study was published in the Morbidity and Mortality Weekly Report.
Health Landscape
Public health data shows a concerning trend as national kindergarten DTaP vaccination rates have dropped to 92.0% for the 2025-26 school year. This shift away from the 2017-18 benchmark of 95.2% complicates efforts to maintain herd immunity against respiratory pathogens like pertussis.
Parents and caregivers should review their children's immunization records to ensure they have completed the full DTaP series by age six. If you have questions about vaccination schedules or the current pertussis risk in your community, have a conversation with your pediatrician.
The takeaway
The DTaP vaccine series is highly effective at preventing pertussis, which remains a significant threat to children. Parents should verify their child's vaccination status with their physician to ensure they remain protected throughout the primary series.
Further reading
For more information on immunization, visit Allergies.
Source note: This article includes information reported by Umn.
Live Poll
Do you believe it is essential for children to complete the full childhood vaccine series?
